annual EBITDA:
$690.00M-$868.00M(-55.71%)Summary
- As of today (June 22, 2025), TEVA annual EBITDA is $690.00 million, with the most recent change of -$868.00 million (-55.71%) on December 31, 2024.
- During the last 3 years, TEVA annual EBITDA has fallen by -$2.19 billion (-76.03%).
- TEVA annual EBITDA is now -87.33% below its all-time high of $5.45 billion, reached on December 31, 2014.
Performance
TEVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$763.00M+$502.00M(+192.34%)Summary
- As of today (June 22, 2025), TEVA quarterly EBITDA is $763.00 million, with the most recent change of +$502.00 million (+192.34%) on March 31, 2025.
- Over the past year, TEVA quarterly EBITDA has increased by +$708.00 million (+1287.27%).
- TEVA quarterly EBITDA is now -62.45% below its all-time high of $2.03 billion, reached on March 31, 2018.
Performance
TEVA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.49B+$708.00M(+91.12%)Summary
- As of today (June 22, 2025), TEVA TTM EBITDA is $1.49 billion, with the most recent change of +$708.00 million (+91.12%) on March 31, 2025.
- Over the past year, TEVA TTM EBITDA has increased by +$164.00 million (+12.41%).
- TEVA TTM EBITDA is now -72.73% below its all-time high of $5.45 billion, reached on December 31, 2014.
Performance
TEVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TEVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.7% | +1287.3% | +12.4% |
| 3 y3 years | -76.0% | +295.6% | -11.6% |
| 5 y5 years | -46.0% | +29.3% | +14.9% |
TEVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -76.0% | +174.6% | -23.2% | +211.6% | -23.1% | +260.4% |
| 5 y | 5-year | -76.0% | +135.4% | -23.2% | +119.3% | -57.8% | +165.9% |
| alltime | all time | -87.3% | +104.5% | -62.5% | +106.1% | -72.7% | +109.7% |
TEVA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $763.00M(+192.3%) | $1.49B(+91.1%) |
| Dec 2024 | $690.00M(-55.7%) | $261.00M(+26.1%) | $777.00M(-48.5%) |
| Sep 2024 | - | $207.00M(-18.5%) | $1.51B(-21.8%) |
| Jun 2024 | - | $254.00M(+361.8%) | $1.93B(+46.1%) |
| Mar 2024 | - | $55.00M(-94.5%) | $1.32B(-15.2%) |
| Dec 2023 | $1.56B(-268.4%) | $994.00M(+58.5%) | $1.56B(-1398.3%) |
| Sep 2023 | - | $627.00M(-276.6%) | -$120.00M(+1400.0%) |
| Jun 2023 | - | -$355.00M(-221.6%) | -$8.00M(-96.7%) |
| Mar 2023 | - | $292.00M(-142.7%) | -$244.00M(-73.7%) |
| Dec 2022 | -$925.00M(-132.1%) | -$684.00M(-192.6%) | -$926.00M(+8318.2%) |
| Sep 2022 | - | $739.00M(-225.0%) | -$11.00M(-105.4%) |
| Jun 2022 | - | -$591.00M(+51.5%) | $202.00M(-88.0%) |
| Mar 2022 | - | -$390.00M(-268.8%) | $1.68B(-41.7%) |
| Dec 2021 | $2.88B(-247.8%) | $231.00M(-75.7%) | $2.88B(-18.1%) |
| Sep 2021 | - | $952.00M(+7.3%) | $3.52B(-351.9%) |
| Jun 2021 | - | $887.00M(+9.5%) | -$1.40B(-19.3%) |
| Mar 2021 | - | $810.00M(-6.7%) | -$1.73B(-11.3%) |
| Dec 2020 | -$1.95B(-252.3%) | $868.00M(-121.9%) | -$1.95B(-13.5%) |
| Sep 2020 | - | -$3.96B(-815.0%) | -$2.25B(-210.4%) |
| Jun 2020 | - | $554.00M(-6.1%) | $2.04B(+57.9%) |
| Mar 2020 | - | $590.00M(+4.6%) | $1.29B(+1.0%) |
| Dec 2019 | $1.28B(+670.5%) | $564.00M(+69.9%) | $1.28B(-160.7%) |
| Sep 2019 | - | $332.00M(-271.1%) | -$2.11B(+8.1%) |
| Jun 2019 | - | -$194.00M(-133.6%) | -$1.95B(+51.1%) |
| Mar 2019 | - | $577.00M(-120.5%) | -$1.29B(-876.5%) |
| Dec 2018 | $166.00M(-101.1%) | -$2.82B(-675.7%) | $166.00M(-101.7%) |
| Sep 2018 | - | $490.00M(+5.4%) | -$9.52B(+4.6%) |
| Jun 2018 | - | $465.00M(-77.1%) | -$9.11B(-38.2%) |
| Mar 2018 | - | $2.03B(-116.2%) | -$14.73B(-4.3%) |
| Dec 2017 | -$15.39B(-631.9%) | -$12.51B(-1482.2%) | -$15.39B(+343.3%) |
| Sep 2017 | - | $905.00M(-117.5%) | -$3.47B(-3.9%) |
| Jun 2017 | - | -$5.16B(-475.5%) | -$3.61B(-288.9%) |
| Mar 2017 | - | $1.38B(-333.4%) | $1.91B(-4.7%) |
| Dec 2016 | $2.89B(-26.4%) | -$589.00M(-177.0%) | $2.01B(-35.9%) |
| Sep 2016 | - | $765.00M(+111.9%) | $3.13B(-15.2%) |
| Jun 2016 | - | $361.00M(-75.4%) | $3.69B(-14.5%) |
| Mar 2016 | - | $1.47B(+174.3%) | $4.32B(+9.8%) |
| Dec 2015 | $3.93B(-27.8%) | $536.00M(-59.5%) | $3.93B(-16.2%) |
| Sep 2015 | - | $1.32B(+34.5%) | $4.69B(-3.1%) |
| Jun 2015 | - | $985.00M(-9.1%) | $4.84B(-6.1%) |
| Mar 2015 | - | $1.08B(-16.5%) | $5.15B(-5.4%) |
| Dec 2014 | $5.45B(+69.9%) | $1.30B(-11.9%) | $5.45B(+7.6%) |
| Sep 2014 | - | $1.47B(+13.4%) | $5.06B(+5.3%) |
| Jun 2014 | - | $1.30B(-5.6%) | $4.81B(+44.7%) |
| Mar 2014 | - | $1.38B(+51.0%) | $3.32B(+3.6%) |
| Dec 2013 | $3.21B(-17.4%) | $911.00M(-25.3%) | $3.21B(+7.3%) |
| Sep 2013 | - | $1.22B(-755.9%) | $2.99B(+41.0%) |
| Jun 2013 | - | -$186.00M(-114.8%) | $2.12B(-42.7%) |
| Mar 2013 | - | $1.26B(+82.2%) | $3.70B(-4.8%) |
| Dec 2012 | $3.88B(-8.9%) | $692.00M(+96.6%) | $3.88B(-7.9%) |
| Sep 2012 | - | $352.00M(-74.7%) | $4.21B(-18.1%) |
| Jun 2012 | - | $1.39B(-3.9%) | $5.14B(+6.2%) |
| Mar 2012 | - | $1.45B(+41.4%) | $4.84B(+6.9%) |
| Dec 2011 | $4.26B(-11.7%) | $1.02B(-20.2%) | $4.53B(+0.5%) |
| Sep 2011 | - | $1.28B(+17.3%) | $4.51B(-3.5%) |
| Jun 2011 | - | $1.09B(-3.5%) | $4.67B(-4.4%) |
| Mar 2011 | - | $1.13B(+13.2%) | $4.89B(+1.3%) |
| Dec 2010 | $4.83B(+45.6%) | $1.00B(-30.8%) | $4.83B(+7.8%) |
| Sep 2010 | - | $1.45B(+10.6%) | $4.48B(+10.9%) |
| Jun 2010 | - | $1.31B(+22.4%) | $4.04B(+17.7%) |
| Mar 2010 | - | $1.07B(+64.0%) | $3.43B(+18.3%) |
| Dec 2009 | $3.31B(+102.3%) | $652.00M(-35.3%) | $2.90B(+87.9%) |
| Sep 2009 | - | $1.01B(+43.4%) | $1.54B(+17.5%) |
| Jun 2009 | - | $702.00M(+30.5%) | $1.31B(-4.2%) |
| Mar 2009 | - | $538.00M(-176.4%) | $1.37B(-16.3%) |
| Dec 2008 | $1.64B(-43.8%) | -$704.00M(-190.6%) | $1.64B(-47.9%) |
| Sep 2008 | - | $777.00M(+2.2%) | $3.14B(+0.4%) |
| Jun 2008 | - | $760.00M(-5.6%) | $3.13B(-0.2%) |
| Mar 2008 | - | $805.00M(+0.5%) | $3.14B(+7.6%) |
| Dec 2007 | $2.92B(+15.4%) | $801.00M(+4.7%) | $2.92B(+10.4%) |
| Sep 2007 | - | $765.00M(-0.3%) | $2.64B(-2.5%) |
| Jun 2007 | - | $767.00M(+31.6%) | $2.71B(-1.4%) |
| Mar 2007 | - | $583.00M(+10.7%) | $2.75B(+7.4%) |
| Dec 2006 | $2.53B(+62.5%) | $526.80M(-36.8%) | $2.56B(+7.0%) |
| Sep 2006 | - | $833.70M(+3.6%) | $2.39B(+27.9%) |
| Jun 2006 | - | $805.10M(+104.9%) | $1.87B(+36.1%) |
| Mar 2006 | - | $393.00M(+9.1%) | $1.37B(+0.5%) |
| Dec 2005 | $1.55B | $360.30M(+15.4%) | $1.37B(+1.8%) |
| Sep 2005 | - | $312.20M(+1.2%) | $1.34B(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2005 | - | $308.60M(-20.1%) | $1.35B(+0.9%) |
| Mar 2005 | - | $386.40M(+15.0%) | $1.34B(+13.8%) |
| Dec 2004 | $1.39B(+37.6%) | $336.00M(+5.8%) | $1.18B(+10.3%) |
| Sep 2004 | - | $317.70M(+6.9%) | $1.07B(+12.8%) |
| Jun 2004 | - | $297.10M(+32.5%) | $944.90M(+1.6%) |
| Mar 2004 | - | $224.20M(-1.0%) | $929.70M(+5.1%) |
| Dec 2003 | $1.01B(+63.1%) | $226.50M(+14.9%) | $884.80M(+5.2%) |
| Sep 2003 | - | $197.10M(-30.1%) | $840.90M(+9.9%) |
| Jun 2003 | - | $281.90M(+57.2%) | $765.40M(+28.6%) |
| Mar 2003 | - | $179.30M(-1.8%) | $595.10M(+13.6%) |
| Dec 2002 | $620.90M(+27.9%) | $182.60M(+50.2%) | $524.00M(+15.6%) |
| Sep 2002 | - | $121.60M(+9.0%) | $453.16M(+5.2%) |
| Jun 2002 | - | $111.60M(+3.1%) | $430.56M(+6.1%) |
| Mar 2002 | - | $108.20M(-3.2%) | $405.81M(+7.8%) |
| Dec 2001 | $485.58M(+3.3%) | $111.76M(+12.9%) | $376.51M(-14.6%) |
| Sep 2001 | - | $99.00M(+14.0%) | $440.71M(+5.9%) |
| Jun 2001 | - | $86.85M(+10.1%) | $416.13M(-1.6%) |
| Mar 2001 | - | $78.90M(-55.2%) | $422.74M(+5.7%) |
| Dec 2000 | $470.19M(+40.0%) | $175.95M(+136.4%) | $399.83M(+13.0%) |
| Sep 2000 | - | $74.42M(-20.4%) | $353.94M(+6.9%) |
| Jun 2000 | - | $93.46M(+66.9%) | $331.17M(+17.2%) |
| Mar 2000 | - | $56.00M(-56.9%) | $282.45M(+5.6%) |
| Dec 1999 | $335.89M(+28.0%) | $130.07M(+151.9%) | $267.37M(+10.5%) |
| Sep 1999 | - | $51.64M(+15.4%) | $241.94M(+5.2%) |
| Jun 1999 | - | $44.74M(+9.3%) | $229.99M(+10.1%) |
| Mar 1999 | - | $40.92M(-60.9%) | $208.85M(+2.6%) |
| Dec 1998 | $262.48M(+16.2%) | $104.63M(+163.6%) | $203.53M(-136.9%) |
| Sep 1998 | - | $39.70M(+68.2%) | -$552.30M(+80.9%) |
| Jun 1998 | - | $23.60M(-33.7%) | -$305.30M(+424.5%) |
| Mar 1998 | - | $35.60M(-105.5%) | -$58.20M(-133.5%) |
| Dec 1997 | $225.80M(+30.5%) | -$651.20M(-327.1%) | $173.80M(-37.5%) |
| Sep 1997 | - | $286.70M(+5.9%) | $278.20M(+22.0%) |
| Jun 1997 | - | $270.70M(+1.2%) | $228.10M(+9.9%) |
| Mar 1997 | - | $267.60M(-148.9%) | $207.60M(+60.6%) |
| Dec 1996 | $173.00M(+26.1%) | -$546.80M(-331.1%) | $129.30M(-57.7%) |
| Sep 1996 | - | $236.60M(-5.4%) | $305.50M(+30.4%) |
| Jun 1996 | - | $250.20M(+32.2%) | $234.20M(+66.3%) |
| Mar 1996 | - | $189.30M(-151.1%) | $140.80M(+35.1%) |
| Dec 1995 | $137.20M(+2.2%) | -$370.60M(-324.2%) | $104.20M(-31.1%) |
| Sep 1995 | - | $165.30M(+5.4%) | $151.20M(+16.8%) |
| Jun 1995 | - | $156.80M(+2.7%) | $129.40M(+8.3%) |
| Mar 1995 | - | $152.70M(-147.2%) | $119.50M(+15.5%) |
| Dec 1994 | $134.30M(+24.8%) | -$323.60M(-325.5%) | $103.50M(-28.3%) |
| Sep 1994 | - | $143.50M(-2.3%) | $144.40M(+12.7%) |
| Jun 1994 | - | $146.90M(+7.5%) | $128.10M(+20.6%) |
| Mar 1994 | - | $136.70M(-148.4%) | $106.20M(+20.8%) |
| Dec 1993 | $107.60M(+47.8%) | -$282.70M(-322.2%) | $87.90M(-41.6%) |
| Sep 1993 | - | $127.20M(+1.8%) | $150.50M(+29.4%) |
| Jun 1993 | - | $125.00M(+5.6%) | $116.30M(+38.0%) |
| Mar 1993 | - | $118.40M(-153.8%) | $84.30M(+43.4%) |
| Dec 1992 | $72.80M(+10.5%) | -$220.10M(-336.7%) | $58.80M(-32.1%) |
| Sep 1992 | - | $93.00M(0.0%) | $86.60M(+19.8%) |
| Jun 1992 | - | $93.00M(+0.1%) | $72.30M(+26.6%) |
| Mar 1992 | - | $92.90M(-148.3%) | $57.10M(+10.9%) |
| Dec 1991 | $65.90M(+24.6%) | -$192.30M(-344.3%) | $51.50M(-45.8%) |
| Sep 1991 | - | $78.70M(+1.2%) | $95.00M(+20.4%) |
| Jun 1991 | - | $77.80M(-10.9%) | $78.90M(+11.6%) |
| Mar 1991 | - | $87.30M(-158.7%) | $70.70M(+44.0%) |
| Dec 1990 | $52.90M(+19.4%) | -$148.80M(-337.7%) | $49.10M(+6.0%) |
| Sep 1990 | - | $62.60M(-10.1%) | $46.30M(-2.5%) |
| Jun 1990 | - | $69.60M(+5.9%) | $47.50M(+1.7%) |
| Mar 1990 | - | $65.70M(-143.3%) | $46.70M(-5.1%) |
| Dec 1989 | $44.30M(+46.2%) | -$151.60M(-337.6%) | $49.20M(-37.4%) |
| Sep 1989 | - | $63.80M(-7.3%) | $78.60M(+28.0%) |
| Jun 1989 | - | $68.80M(+0.9%) | $61.40M(+43.8%) |
| Mar 1989 | - | $68.20M(-155.8%) | $42.70M(+74.3%) |
| Dec 1988 | $30.30M(+24.2%) | -$122.20M(-362.2%) | $24.50M(-83.3%) |
| Sep 1988 | - | $46.60M(-7.0%) | $146.70M(+14.1%) |
| Jun 1988 | - | $50.10M(+0.2%) | $128.60M(+22.6%) |
| Mar 1988 | - | $50.00M(+75.4%) | $104.90M(+2284.1%) |
| Sep 1987 | - | $28.50M(+8.0%) | $4.40M(-59.3%) |
| Jun 1987 | - | $26.40M(-130.9%) | $10.80M(-44.0%) |
| Mar 1987 | $24.40M(+58.4%) | -$85.40M(-344.7%) | $19.30M(-60.0%) |
| Dec 1986 | - | $34.90M(0.0%) | $48.20M(+33.5%) |
| Sep 1986 | - | $34.90M(0.0%) | $36.10M(+50.4%) |
| Jun 1986 | - | $34.90M(-161.8%) | $24.00M(+101.7%) |
| Mar 1986 | $15.40M | -$56.50M(-347.8%) | $11.90M(-82.6%) |
| Dec 1985 | - | $22.80M(0.0%) | $68.40M(+50.0%) |
| Sep 1985 | - | $22.80M(0.0%) | $45.60M(+100.0%) |
| Jun 1985 | - | $22.80M | $22.80M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual EBITDA?
- What is the all time high annual EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual EBITDA year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly EBITDA?
- What is the all time high quarterly EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly EBITDA year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM EBITDA?
- What is the all time high TTM EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM EBITDA year-on-year change?
What is Teva Pharmaceutical Industries Limited annual EBITDA?
The current annual EBITDA of TEVA is $690.00M
What is the all time high annual EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual EBITDA is $5.45B
What is Teva Pharmaceutical Industries Limited annual EBITDA year-on-year change?
Over the past year, TEVA annual EBITDA has changed by -$868.00M (-55.71%)
What is Teva Pharmaceutical Industries Limited quarterly EBITDA?
The current quarterly EBITDA of TEVA is $763.00M
What is the all time high quarterly EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly EBITDA is $2.03B
What is Teva Pharmaceutical Industries Limited quarterly EBITDA year-on-year change?
Over the past year, TEVA quarterly EBITDA has changed by +$708.00M (+1287.27%)
What is Teva Pharmaceutical Industries Limited TTM EBITDA?
The current TTM EBITDA of TEVA is $1.49B
What is the all time high TTM EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM EBITDA is $5.45B
What is Teva Pharmaceutical Industries Limited TTM EBITDA year-on-year change?
Over the past year, TEVA TTM EBITDA has changed by +$164.00M (+12.41%)